Versuchen GOLD - Frei

Direct tax mop-up rises 8%, tax relief tempers growth

Mint Chennai

|

December 20, 2025

Collections grow at slower than projected 13%; non-tax revenue robust on RBI dividend

- Gireesh Chandra Prasad

Direct tax mop-up rises 8%, tax relief tempers growth

Disinflation also affected tax revenue buoyancy. In the three months to November, CPI-based inflation was below RBI's target range of 2-6%.

(ISTOCKPHOTO)

The Centre’s direct tax revenue collection, after adjusting for refunds, stood at ₹17 trillion in the April to mid-December period, rising 8% year-on-year, official data showed.

The growth was slower than the projected 13% increase, as tax relief granted to individuals moderated revenue growth from personal income taxes. Data released by the Central Board of Direct Taxes (CBDT) on Friday showed that tax receipts from corporations and individuals between 1 April and 17 December accounted for two-thirds of the full-year target of ₹25.2 trillion.

Companies paid over ₹8.17 trillion during the period after adjusting for refunds, registering a 10.5% increase year-on-year, in line with the growth rate projected in the Union budget for FY26, presented on 1 February.

Individuals have paid about ₹8.47 trillion so far this financial year after adjusting for refunds, marking a 6.4% growth. However, this is slower than the 14.4% growth projected for net personal income tax receipts this year.

WEITERE GESCHICHTEN VON Mint Chennai

Mint Chennai

Mint Chennai

Lenskart wants artificial intelligence to test your eyes

It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

More companies to take a hit as labour codes debut

Reworked gratuity and leave encashments spell additional expenses for India Inc

time to read

2 mins

January 13, 2026

Mint Chennai

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Chennai

Trump’s investigation of Powell is also a warning to the next Fed chair

The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

States flag Almont-Kid syrup as tests find contaminants

Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol

time to read

1 mins

January 13, 2026

Mint Chennai

Mint Chennai

India at 100: Our choices today will define the next two decades

India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path

time to read

4 mins

January 13, 2026

Mint Chennai

Now, inheritance works without probate—but why it still matters

Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases

time to read

6 mins

January 13, 2026

Mint Chennai

Why VCs have a new deep-tech playbook

where fundraising starts to drag,\" said Chand.

time to read

1 min

January 13, 2026

Mint Chennai

TCS, HCLTech deliver Q3 revenue surprise

clearer.

time to read

2 mins

January 13, 2026

Mint Chennai

Mint Chennai

US productivity is rising and it risks warping monetary policy

America's neutral rate ought to be going up but will the Fed listen?

time to read

3 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size